Login

Navigating Industrial Evolution: Meeting Demand, Managing Costs, and Innovating in Critical Services 00:10:00

Share On Facebook Share On Twitter

Scott Salmirs, CEO of ABM Industries

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:00:00
Priya Sampathkumar, M.D. Critical Care Specialist, Mayo Clinic
00:10:00
N-able highlights collaboration and features John Pagliuca discussing transformation and MDR strategies in a MarketBuilder update.
00:10:00
Alma Media Navigates Challenging Market Conditions with Strategic Investments in Product Development | Kai Telanne, CEO, Alma Media Oyj.
00:10:00
Nick Grant, President and CEO of inTEST Corporation, delves into the company's transformation, growth markets, and future initiatives during an interview on NYSE Floor Talk with Judy Shaw.|Nick Grant, President and CEO of inTEST Corporation
00:10:00
IAMGOLD CEO Renald Adams Discusses Kot Gold Ramp-Up, Cost Targets, and Financial Strategy
00:10:00
Taking Action Amid Election Uncertainty
00:10:00
From Romania to NASA to Silicon Valley|Oana Olteanu,Partner,SignalFire
00:10:00
President and CEO of CUC, Mr. Richard Hew, discusses reasons behind decisions and strategies at Caribbean Utilities Company Ltd.
00:10:00
supporting, mentoring, and investing in companies and startups at all stages of growth|Bill Liao, General Partner, venture fund SOSV
00:10:00
high growth companies led by management teams inclusive of women|Edith Dorsen,Founder and Managing Director,Womens Venture Capital Fund
00:10:00
Allegion Chairman, President, and CEO Dave Petratis has been named a “CEO Who Gets It” by the National Safety Council.|John Stone is president and chief executive officer (CEO) for Allegion, as well as a member of the company’s Board of Directors.
00:10:00
CanAlaska Highlights New High-Grade Discovery at Pike Zone

© 2026 Nehu